Institutional investors fund conviction, and conviction is built on rigour. We refine the business model narrative, construct three-statement financial models that withstand intense diligence, and produce investment collateral engineered to the standards of tier-1 venture capital and private equity platforms.
Beyond primary equity, we structure tailored capital solutions including growth debt, mezzanine facilities, and working capital optimization to support balance sheet resilience and growth mandates - matching the instrument to the enterprise, not the reverse.
Our syndication reach spans venture capital, private equity, and institutional family offices across North America, Europe, and Asia. We run confidential, anonymised outreach to pre-screened investors, manage Q&A and management meetings, and negotiate term sheet mechanics to close.
Advising an Indian fabless semiconductor and AI-enabled mobility technology company on its Pre-Series A fundraising to accelerate product commercialisation and international expansion.
Advising an integrated healthcare technology and pharmaceutical commerce platform on institutional fundraising to support business expansion and technology scaling.
Advising a pharmaceutical manufacturing company on strategic capital raising to expand manufacturing capacity and strengthen market position.
